SAN DIEGO--(EON: Enhanced Online News)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
- Kevin Sayer, President and Chief Executive Officer, will present an update on the company at the J.P. Morgan 35th Annual Healthcare Conference in San Francisco, California on Tuesday, January 10, 2017 at 10:30am (PST). The presentation, which will occur live at the Westin St. Francis Hotel, will be concurrently webcast.
The link to the webcast will be available on the DexCom website at www.dexcom.com by navigating to “Our Company,” then “Investor Relations,” and finally “Events and Webcasts” and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
DexCom is a medical device company with a limited operating history. Successful commercialization of the company's products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company's development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company's annual report on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission on February 25, 2015.